Technical analysis of Kymera Therapeutics, Inc. (KYMR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins.
Price Performance
| 1 month | -4.16% |
| 3 months | +28.64% |
| Year-to-date | +49.51% |
| 1 year | +141.75% |
| 3 years | +509.38% |
| 5 years | +84.80% |
52-Week Range
| 52-week High | $130.05 |
| 52-week Low | $47.86 |
| Avg Volume (90d) | 765K |
Technical Indicators
| SMA 50 | $114.34 |
| SMA 200 | $90.83 |
| Beta | 2.29 |
| 30-day Volatility (annualised) | 34.6% |
| Price vs SMA 50 | +1.7% |
| Price vs SMA 200 | +28.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $61.84 | |
| 2025-11 | $67.88 | +9.8% |
| 2025-12 | $77.81 | +14.6% |
| 2026-01 | $72.69 | -6.6% |
| 2026-02 | $91.35 | +25.7% |
| 2026-03 | $83.29 | -8.8% |
| 2026-04 | $81.07 | -2.7% |
| 2026-05 | $81.42 | +0.4% |
| 2026-06 | $114.67 | +40.8% |
| 2026-07 | $103.40 | -9.8% |
| 2026-08 | $118.81 | +14.9% |
| 2026-09 | $116.33 | -2.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $116.33 |
| Market Cap | $9.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 7.56 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.05 |
| Current Ratio | 9.83 |